Want to join the conversation?
$GILD said the European Commission has granted marketing authorization for once-daily single tablet regimen (STR) Odefsey for treatment of HIV-1 infection in certain patients. Odefsey combines $GILD's emtricitabine and tenofovir alafenamide with rilpivirine, marketed by Janssen Sciences Ireland UC, a $JNJ's Janssen Pharmaceutical company.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?